Romain Haudecoeur

Grenoble, 38000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Thioureas, thiosemicarbazones, hydroxamic acids and related compounds as copper-chelating tyrosinase inhibitors.

Thioureas, thiosemicarbazones, hydroxamic acids and related compounds as copper-chelating tyrosinase inhibitors.

Journal: European journal of medicinal chemistry

Published: April 03, 2026

Hydroquinone causes exogenous ochronosis through tyrosinase catalytic activity and highlights the need for genuine human tyrosinase inhibitors.

Hydroquinone causes exogenous ochronosis through tyrosinase catalytic activity and highlights the need for genuine human tyrosinase inhibitors.

Journal: The British journal of dermatology

Published: July 31, 2025

Tyrosinase Inhibition and Antimelanogenic Effects of Resorcinol-Containing Compounds.

Tyrosinase Inhibition and Antimelanogenic Effects of Resorcinol-Containing Compounds.

Journal: ChemMedChem

Published: April 29, 2024

Design and Synthesis of Novel Amino and Acetamidoaurones with Antimicrobial Activities.

Design and Synthesis of Novel Amino and Acetamidoaurones with Antimicrobial Activities.

Journal: Antibiotics (Basel, Switzerland)

Published: February 23, 2024

Expanding Chemical Frontiers: Approaches for Generating Diverse and Bioactive Natural Product-Like Compounds Libraries from Extracts.

Expanding Chemical Frontiers: Approaches for Generating Diverse and Bioactive Natural Product-Like Compounds Libraries from Extracts.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: December 14, 2023

Design and synthesis of 4-amino-2',4'-dihydroxyindanone derivatives as potent inhibitors of tyrosinase and melanin biosynthesis in human melanoma cells.

Design and synthesis of 4-amino-2',4'-dihydroxyindanone derivatives as potent inhibitors of tyrosinase and melanin biosynthesis in human melanoma cells.

Journal: European journal of medicinal chemistry

Published: October 16, 2023

Aurones and derivatives as promising New Delhi metallo-β-lactamase (NDM-1) inhibitors.

Aurones and derivatives as promising New Delhi metallo-β-lactamase (NDM-1) inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: July 10, 2023

Catechol-mimicking transition-state analogues as non-oxidizable inhibitors of tyrosinases.

Catechol-mimicking transition-state analogues as non-oxidizable inhibitors of tyrosinases.

Journal: European journal of medicinal chemistry

Published: May 22, 2023

Bioactive Aurones, Indanones, and Other Hemiindigoid Scaffolds: Medicinal Chemistry and Photopharmacology Perspectives.

Bioactive Aurones, Indanones, and Other Hemiindigoid Scaffolds: Medicinal Chemistry and Photopharmacology Perspectives.

Journal: Journal of medicinal chemistry

Published: September 20, 2022

Resorcinol-based hemiindigoid derivatives as human tyrosinase inhibitors and melanogenesis suppressors in human melanoma cells.

Resorcinol-based hemiindigoid derivatives as human tyrosinase inhibitors and melanogenesis suppressors in human melanoma cells.

Journal: European journal of medicinal chemistry

Published: July 21, 2022

β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy.

β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy.

Journal: Journal of medicinal chemistry

Published: February 02, 2021

Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.

Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.

Journal: Journal of medicinal chemistry

Published: August 14, 2020

Showing 1-12 of 33

Last Updated: 09/26/2026